Prothena Capital Management Services Limited maintains full compliance with the provisions of the AIFM Law L. 56(I)/2013, Directive 2011/61/EU (AIFMD), and all relevant CySEC directives. Our internal policies and governance structures are designed to meet the highest standards of regulatory oversight
Marketing & Distribution Compliance
Prothena Capital Management Services Limited fully complies with Regulation (EU) 2019/1156 governing the cross-border distribution of Alternative Investment Funds (AIFs) within the European Union. The company ensures that all pre-marketing activities are properly notified to both home and host state regulators. In addressing professional and well-informed investors across multiple jurisdictions, Prothena Capital Management Services Limited maintains a high standard of consistency and transparency. All marketing practices are carefully aligned with the harmonized EU framework, supporting investor protection and regulatory cooperation throughout the Union.
Marketing Restrictions
Prothena Capital Management Services Limited adheres to the principles set out under the AIFMD regarding investor communication and access to fund information. All marketing materials are clearly designated as promotional in nature and do not constitute investment advice or a MiFID-regulated service. Access to detailed fund documentation and offering materials is restricted exclusively to professional and well-informed investors as defined by Cyprus Law and applicable EU regulations. Retail investors are presented with a clear disclaimer, requiring confirmation of their investor classification before being granted access to any fund-specific content. These safeguards are implemented through website disclaimers, investor categorization protocols, and jurisdiction-based content controls, ensuring compliance with regulatory expectations across all markets in which Prothena operates.